Brain

Neu Health Launches in U.S., Supported by FDA Clearance for Parkinson’s Tremor Measurement

Delivering precision neurology via smartphone, Neu Health is built on the Oxford Discovery Cohort, one of the world's largest longitudinal…

5 months ago

Ocutrx Appoints Top Neurosurgeon Dr. Robert Louis to Scientific Advisory Board, Introduces DigiLoupes™ for Brain Surgery

Dr. Robert Louis Joins the Board to Advance Ocutrx's DigiLoupes Technology for Neurosurgical Applications IRVINE, Calif., July 29, 2025 /PRNewswire/…

5 months ago

Creyos Featured in Alzheimer’s Research at AAIC 2025

Findings from Western University, QIMR Berghofer, and Rotman Research Institute underscore the power of Creyos in detecting early risk, validating digital…

5 months ago

MAUI Imaging Highlights Publication Of Baseline Imaging Analysis for Traumatic Injuries Showing Imaging Breakthrough

Computed Echo Tomography (CET) Described as Addressing Limitations of Conventional Ultrasound TUCSON, Ariz., July 29, 2025 /PRNewswire/ -- MAUI Imaging,…

5 months ago

Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference

SEATTLE and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty…

5 months ago

Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease

- Pioneering approach to halting the chronic neuroinflammation responsible for neurodegeneration- Trial to assess safety, PK and detect early signs…

5 months ago

ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference

Presentation to highlight the Company’s proprietary protein-misfolding platform, EpiSelectTM, used to develop PMN310 Posters highlighting PRECISE-AD, the Company’s Phase 1b…

5 months ago

Cingulate Receives $4.3M Waiver from FDA Ahead of Imminent Filing for Marketing Approval of Lead ADHD Asset CTx-1301

PDUFA Fee Waiver comes Days before Planned Submission of New Drug ApplicationKANSAS CITY, Kan., July 29, 2025 (GLOBE NEWSWIRE) --…

5 months ago

Praxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial Results

BOSTON, July 29, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…

5 months ago

Cognition Therapeutics Presents Data at AAIC Highlighting Broad Neurological Impact of Zervimesine (CT1812) in Dementia with Lewy Bodies and Alzheimer’s Disease

- Zervimesine’s impact on debilitating DLB behavioral symptoms highlighted in podium presentation -- Plasma p-tau217 levels can identify Alzheimer’s patients…

5 months ago